Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Conference Call, Webcast

Philip Morris International Inc. Reports 2021 Third-Quarter Reported Diluted EPS of $1.55 and Adjusted Diluted EPS of $1.58, Representing Currency-Neutral Growth of 8.5%


Regulatory News:

Philip Morris International Inc. (NYSE: PM) today announces its 2021 third-quarter results. Growth rates presented in this press release on an organic basis reflect currency-neutral underlying results. Adjusted net revenues exclude the impact related to the Saudi Arabia customs assessments. A glossary of key terms, definitions and explanatory notes is included at the end of this press release. Adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures are included in the schedules to this press release.

2021 THIRD-QUARTER & YEAR-TO-DATE HIGHLIGHTS

2021 Third-Quarter

2021 Nine Months Year-to-Date

"Our business delivered another strong quarterly performance, coming ahead of our expectations with adjusted diluted EPS of $1.58, representing growth of 8.5%, excluding currency," said Jacek Olczak, Chief Executive Officer.

"The continued excellent performance of IQOS drove total shipment volume and organic net revenue growth of 2.1% and 7.6%, respectively, and was complemented by further sequential share gains for our combustible products."

"Today, we are reaffirming our strong growth outlook for 2021, with an adjusted diluted EPS forecast toward the upper-half of our previous range and representing currency-neutral growth of 13% to 14%, despite ongoing tightness in device supplies due to the global shortage of semiconductors, which impacts our ability to fulfill consumer demand for IQOS."

"We confirm our confidence in our 2021 to 2023 growth targets, despite device constraints that could persist into the first half of 2022, with temporarily lower IQOS user growth rates."

2021 FULL-YEAR FORECAST

 

Full-Year

 

2021
Forecast

 

2020

 

Growth

 

 

 

 

 

 

 

 

Reported Diluted EPS

$5.77

-

$5.82

$ 5.16

 

 

 

 

Saudi Arabia customs assessments

0.14

?

 

 

 

 

Asset impairment and exit costs

0.09

0.08

 

 

 

 

Asset acquisition cost

0.03

?

 

 

 

 

Equity investee ownership dilution

(0.02)

?

 

 

 

 

Fair value adjustment for equity security investments

 

0.04

 

 

 

 

Tax items

 

(0.06

)

 

 

 

Brazil indirect tax credit

 

(0.05

)

 

 

 

Adjusted Diluted EPS

$6.01

-

$6.06

$ 5.17

 

 

 

 

Currency

(0.17)

 

 

 

 

Adjusted Diluted EPS, excluding currency

$5.84

-

$5.89

$ 5.17

 

13%

-

14%

PMI revises and narrows its full-year reported diluted EPS forecast to a range of $5.77 to $5.82, at prevailing exchange rates, from a range of $5.76 to $5.86 previously, primarily reflecting:

This forecast represents a projected currency-neutral increase in adjusted diluted EPS of around 13% to 14% versus adjusted diluted EPS of $5.17 in 2020, as outlined in the table above.

2021 Full-Year Forecast Assumptions

This forecast assumes:

The foregoing is underpinned by the assumption that, even in the event of prolonged pandemic-related restrictions, there will not be a return to the depressed consumption levels of the second quarter of 2020. This assumption is consistent with the less severe impact on consumption levels observed in the second half of 2020 as COVID-19 spread in a number of markets.

This forecast excludes the impact of any future acquisitions, unanticipated or unquantifiable asset impairment and exit cost charges, future changes in currency exchange rates, further developments pertaining to the judgment in the two Québec Class Action lawsuits and the Companies' Creditors Arrangement Act (CCAA) protection granted to PMI's Canadian subsidiary, Rothmans, Benson & Hedges, Inc. (RBH), any unusual events, any intensification of the global shortage of semiconductors and the related impact on the supply of our electronic devices, and any COVID-19-related developments different from the assumptions set forth in the company's forecast.

Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.

IQOS Device Supply

As communicated in September, the global semiconductor shortage is resulting in a tightness in IQOS device supply. This is affecting the availability and assortment of IQOS devices in certain markets, which is hampering the company's ability to operate at full commercial and competitive capacity to fully meet demand. This has been reflected in lower IQOS user growth rates in the third quarter.

At this stage, supply forecasting remains volatile. PMI therefore assumes that the tight supply situation will persist into the first half of 2022 and, where necessary, the company will prioritize device replacements for existing IQOS users over device sales targeting user acquisition. PMI is also adjusting its launch timeline for IQOS ILUMA outside Japan, with additional major launches now assumed for the second half of 2022.

PMI views this as a temporary phenomenon and expects IQOS user growth to re-accelerate once shortages ease, as consumer demand remains robust. PMI confirms its confidence in its 2021 to 2023 organic compound annual growth targets for net revenues and adjusted diluted EPS (more than 5% and 9%, respectively), though there are short-term shortage scenarios under which the transitory IQOS device supply impact on user growth could result in full-year 2022 organic growth rates below the company's 2021 to 2023 growth targets.

Acquisitions

On August 9, 2021, PMI acquired 100% of OtiTopic, Inc., a U.S. respiratory drug development company with a late-stage dry powder inhalation aspirin treatment for acute myocardial infarction. The cost of the acquisition was $51 million, excluding potential additional contingent payments related to the achievement of certain milestones.

On September 15, 2021, PMI acquired 100% of Fertin Pharma A/S, a Danish company that is a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems, for a total consideration of DKK 5.2 billion (approximately $820 million).

As of September 30, 2021, PMI held a 96.86% controlling interest in Vectura Group plc (Vectura), an inhaled therapeutics company based in the United Kingdom, following a series of purchases of Vectura shares and valid acceptances of PMI's offer at a price of 165 pence per share. The delisting and cancellation of trading of Vectura shares was effective as of today. PMI intends to exercise its right to compulsorily acquire the remaining shares of Vectura, in accordance with applicable English law.

Conference Call

A conference call, hosted by Emmanuel Babeau, Chief Financial Officer, will be webcast at 9:00 a.m., Eastern Time, on October 19, 2021. Access is at www.pmi.com/2021Q3earnings.

CONSOLIDATED SHIPMENT VOLUME & MARKET SHARE

PMI Shipment Volume by Region

 

Third-Quarter

 

Nine Months Year-to-Date

(million units)

 

2021

2020

Change

 

2021

2020

Change

Cigarettes

 

 

 

 

 

 

 

 

European Union

 

41,965

 

45,179

 

(7.1

)%

 

120,238

 

126,142

 

(4.7

)%

Eastern Europe

 

25,020

 

25,661

 

(2.5

)%

 

67,771

 

70,737

 

(4.2

)%

Middle East & Africa

 

35,166

 

30,903

 

13.8

%

 

93,155

 

88,087

 

5.8

%

South & Southeast Asia

 

35,578

 

37,238

 

(4.5

)%

 

105,787

 

108,179

 

(2.2

)%

East Asia & Australia

 

11,120

 

10,784

 

3.1

%

 

33,450

 

35,154

 

(4.8

)%

Americas

 

15,994

 

15,699

 

1.9

%

 

46,092

 

45,542

 

1.2

%

Total PMI

 

164,843

 

165,464

 

(0.4

)%

 

466,493

 

473,841

 

(1.6

)%

 

 

 

 

 

 

 

 

 

Heated Tobacco Units

 

 

 

 

 

 

 

 

European Union

 

7,058

 

5,181

 

36.2

%

 

20,405

 

14,069

 

45.0

%

Eastern Europe

 

6,119

 

4,882

 

25.3

%

 

18,594

 

14,374

 

29.4

%

Middle East & Africa

 

577

 

179

 

+100%

 

1,485

 

834

 

78.1

%

South & Southeast Asia

 

79

 

10

 

+100%

 

151

 

10

 

+100%

East Asia & Australia

 

9,435

 

8,601

 

9.7

%

 

28,478

 

24,799

 

14.8

%

Americas

 

221

 

114

 

93.9

%

 

466

 

316

 

47.5

%

Total PMI

 

23,489

 

18,967

 

23.8

%

 

69,579

 

54,402

 

27.9

%

 

 

 

 

 

 

 

 

 

Cigarettes and Heated Tobacco Units

 

 

 

 

 

 

 

 

European Union

 

49,023

 

50,360

 

(2.7

)%

 

140,643

 

140,211

 

0.3

%

Eastern Europe

 

31,139

 

30,543

 

2.0

%

 

86,365

 

85,111

 

1.5

%

Middle East & Africa

 

35,743

 

31,082

 

15.0

%

 

94,640

 

88,921

 

6.4

%

South & Southeast Asia

 

35,657

 

37,248

 

(4.3

)%

 

105,938

 

108,189

 

(2.1

)%

East Asia & Australia

 

20,555

 

19,385

 

6.0

%

 

61,928

 

59,953

 

3.3

%

Americas

 

16,215

 

15,813

 

2.5

%

 

46,558

 

45,858

 

1.5

%

Total PMI

 

188,332

 

184,431

 

2.1

%

 

536,072

 

528,243

 

1.5

%

Third-Quarter

PMI's total shipment volume increased by 2.1%, driven by:

partly offset by

Impact of Inventory Movements

Excluding the net favorable impact of estimated distributor inventory movements of approximately 2.8 billion units, PMI's total in-market sales increased by 0.6%, driven by a 20.2% increase in heated tobacco units, partly offset by a 1.8% decrease in cigarettes.

The net favorable impact of approximately 2.8 billion units reflected:

PMI's total heated tobacco unit in-market sales volume in the quarter was 24.6 billion units, reflecting sequential growth of 7.2% compared to the second quarter of 2021.

Nine Months Year-to-Date

PMI's total shipment volume increased by 1.5%, driven by:

partly offset by

Impact of Inventory Movements

Excluding the net favorable impact of estimated distributor inventory movements of approximately 5.0 billion units, PMI's total in-market sales increased by 0.5%, driven by a 23.3% increase in heated tobacco units, partly offset by a 2.1% decrease in cigarettes.

The net favorable impact of approximately 5.0 billion units reflected:

PMI's total heated tobacco unit in-market sales volume in the nine months year-to-date was 68.8 billion units.

PMI Shipment Volume by Brand

PMI Shipment Volume by Brand

 

Third-Quarter

 

Nine Months Year-to-Date

(million units)

 

2021

2020

Change

 

2021

2020

Change

Cigarettes

 

 

 

 

 

 

 

 

Marlboro

 

65,139

 

61,581

 

5.8

%

 

177,287

 

175,638

 

0.9

%

L&M

 

21,564

 

24,189

 

(10.9

)%

 

64,028

 

69,215

 

(7.5

)%

Chesterfield

 

15,994

 

13,768

 

16.2

%

 

43,021

 

39,274

 

9.5

%

Philip Morris

 

11,107

 

12,254

 

(9.4

)%

 

31,881

 

34,823

 

(8.4

)%

Parliament

 

11,556

 

9,540

 

21.1

%

 

30,535

 

25,575

 

19.4

%

Sampoerna A

 

9,717

 

7,999

 

21.5

%

 

27,601

 

23,801

 

16.0

%

Dji Sam Soe

 

5,518

 

6,372

 

(13.4

)%

 

16,644

 

18,344

 

(9.3

)%

Bond Street

 

3,042

 

6,441

 

(52.8

)%

 

12,200

 

18,481

 

(34.0

)%

Lark

 

4,070

 

3,846

 

5.8

%

 

11,851

 

12,059

 

(1.7

)%

Next

 

2,388

 

2,327

 

2.7

%

 

6,556

 

6,703

 

(2.2

)%

Others

 

14,748

 

17,147

 

(14.0

)%

 

44,889

 

49,928

 

(10.1

)%

Total Cigarettes

 

164,843

 

165,464

 

(0.4

)%

 

466,493

 

473,841

 

(1.6

)%

Heated Tobacco Units

 

23,489

 

18,967

 

23.8

%

 

69,579

 

54,402

 

27.9

%

Total PMI

 

188,332

 

184,431

 

2.1

%

 

536,072

 

528,243

 

1.5

%

Note: Lark includes Lark Harmony; Next includes Next Dubliss; Philip Morris includes Philip Morris/Dubliss; and Sampoerna A includes Sampoerna.

Third-Quarter

The increase in PMI's heated tobacco unit shipment volume was mainly driven by the EU (notably Italy), Eastern Europe (notably Russia) and Japan.

PMI's cigarette shipment volume of the following brands increased:

PMI's cigarette shipment volume of the following brands decreased:

International Share of Market

PMI's total international market share (excluding China and the U.S.), defined as PMI's cigarette and heated tobacco unit sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, was flat at 28.0%, reflecting:

PMI's total international cigarette sales volume as a percentage of total industry cigarette sales volume was down by 0.4 points to 25.6%, mainly reflecting lower cigarette market share and/or an unfavorable geographic mix impact, notably in Egypt, France, Japan, the Philippines, Russia and Ukraine, partly offset by Indonesia, PMI Duty-Free and Turkey.

Nine Months Year-to-Date

The increase in PMI's heated tobacco unit shipment volume was mainly driven by the EU (notably Italy), Eastern Europe (notably Russia and Ukraine) and Japan.

PMI's cigarette shipment volume of the following brands increased:

PMI's cigarette shipment volume of the following brands decreased:

International Share of Market

PMI's total international market share (excluding China and the U.S.) decreased by 0.6 points to 27.3%, reflecting:

PMI's total international cigarette sales volume as a percentage of total industry cigarette sales volume was down by 0.9 points to 24.9%, mainly reflecting lower cigarette market share and/or an unfavorable geographic mix impact, notably in Japan, the Philippines, Russia and Ukraine, partly offset by Indonesia and Turkey.

CONSOLIDATED FINANCIAL SUMMARY

Third-Quarter

Financial Summary -

Quarters Ended September 30

Change
Fav./(Unfav.)

Variance
Fav./(Unfav.)

(in millions)

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

Net Revenues  

$8,122

 

$7,446

 

 

9.1

%

7.6

%

 

676

 

107

 

2

 

158

 

439

 

(30

)

Cost of Sales  

(2,596)

 

(2,416)

 

 

(7.5

)%

(5.8

)%

 

(180

)

(40

)

(1

)

?

 

(211

)

72

 

Marketing, Administration and Research Costs  

(2,053)

 

(1,769)

 

 

(16.1)

%

(15.9)

%

 

(284

)

(2

)

(1

)

?

 

?

 

(281

)

Amortization of Intangibles  

(18)

 

(18)

 

 

?

%

?

%

 

?

 

?

 

?

 

?

 

?

 

?

 

Operating Income  

$3,455

 

$3,243

 

 

6.5

%

4.5

%

 

212

 

65

 

?

 

158

 

228

 

(239

)

Asset Impairment & Exit Costs (1)  

(43)

 

?

 

 

?

%

?

%

 

(43

)

?

 

?

 

?

 

?

 

(43

)

Asset Acquisition Cost (1)  

(51)

 

?

 

 

?

%

?

%

 

(51

)

?

 

?

 

?

 

?

 

(51

)

Adjusted Operating Income  

$3,549

 

$3,243

 

 

9.4

%

7.4

%

 

306

 

65

 

?

 

158

 

228

 

(145

)

Adjusted Operating Income Margin  

43.7

%

43.6

%

  0.1 pp

(0.1

)pp

(1) Included in Marketing, Administration and Research Costs above.

Net revenues increased by 7.6% on an organic basis, mainly reflecting: favorable volume/mix, primarily driven by higher heated tobacco unit volume (notably in the EU, particularly Germany, Italy and Poland, as well as Japan, PMI Duty Free and Russia) and higher device volume (primarily in Japan, driven by the launch of IQOS ILUMA), partly offset by lower cigarette volume (mainly in Australia, France, Germany, Italy and the Philippines, partly offset by Indonesia, Japan, PMI Duty Free and Turkey) and unfavorable cigarette mix (mainly in Germany, Japan and Russia); and a favorable pricing variance (notably driven by Japan, the Philippines, Russia and Turkey, partly offset by Indonesia, Poland and Ukraine).

Operating income increased by 4.5%, excluding currency, primarily reflecting: favorable volume/mix, primarily driven by higher heated tobacco unit volume, partly offset by lower cigarette volume and unfavorable cigarette mix (each mainly reflecting the same geographies as for net revenues noted above); a favorable pricing variance; and lower manufacturing costs (driven by productivity gains related to reduced-risk products); partly offset by higher marketing, administration and research costs (due mainly to investments behind reduced-risk products, asset acquisition costs related to OtiTopic, and higher asset impairment and exit costs due to organizational design optimization and product distribution restructuring in South Korea).

Adjusted operating income increased by 7.4% on an organic basis. Adjusted operating income margin decreased by 0.1 point on the same basis, as detailed in Schedule 8.

Nine Months Year-to-Date

Financial Summary -

Nine Months Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 23,301

 

$ 21,250

 

 

9.7

%

6.1

%

 

2,051

 

752

 

2

 

590

 

983

 

(276

)

Saudi Arabia Customs Assessments

 

(246

)

?

 

 

?

%

?

%

 

(246

)

?

 

?

 

?

 

?

 

(246

)

Adjusted Net Revenues

 

$ 23,547

 

$ 21,250

 

 

10.8

%

7.3

%

 

2,297

 

752

 

2

 

590

 

983

 

(30

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues (1)

 

$ 23,301

 

$ 21,250

 

 

9.7

%

6.1

%

 

2,051

 

752

 

2

 

590

 

983

 

(276

)

Cost of Sales

 

(7,223

)

(6,997

)

 

(3.2

)%

0.5

%

 

(226

)

(260

)

(1

)

?

 

(329

)

364

 

Marketing, Administration and Research Costs

 

(5,995

)

(5,435

)

 

(10.3

)%

(8.2

)%

 

(560

)

(112

)

(1

)

?

 

?

 

(447

)

Amortization of Intangibles

 

(55

)

(55

)

 

?

%

1.8

%

 

?

 

(1

)

?

 

?

 

?

 

1

 

Operating Income

 

$ 10,028

 

$ 8,763

 

 

14.4

%

10.1

%

 

1,265

 

379

 

?

 

590

 

654

 

(358

)

Asset Impairment & Exit Costs (2)

 

(170

)

(71

)

 

-(100

)%

-(100

)%

 

(99

)

?

 

?

 

?

 

?

 

(99

)

Saudi Arabia Customs Assessments (3)

 

(246

)

?

 

 

?

%

?

%

 

(246

)

?

 

?

 

?

 

?

 

(246

)

Asset Acquisition Cost (2)

 

(51

)

?

 

 

?

%

?

%

 

(51

)

?

 

?

 

?

 

?

 

(51

)

Adjusted Operating Income

 

$ 10,495

 

$ 8,834

 

 

18.8

%

14.5

%

 

1,661

 

379

 

?

 

590

 

654

 

38

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

44.6

%

41.6

%

 

3.0

pp

2.8

pp

 

 

 

 

 

 

 

(1)  Cost/Other variance includes a reduction in net revenues of $246 million in 2021 related to the Saudi Arabia customs assessments.

(2) Included in Marketing, Administration and Research Costs above.

(3) Included in Net Revenues above.

Net revenues increased by 6.1%, excluding currency, mainly reflecting: favorable volume/mix, primarily driven by higher heated tobacco unit volume (notably in the EU, particularly Germany, Hungary, Italy and Poland, as well as Japan and Russia), partly offset by lower cigarette volume (mainly in the EU Region, notably the Czech Republic, France and Germany, as well as Japan, Kuwait, North Africa, the Philippines, Russia and Ukraine, partially offset by Indonesia, PMI Duty Free, and Turkey); and a favorable pricing variance (notably driven by the Czech Republic, Germany, Japan, Kazakhstan, North Africa, the Philippines, Russia and Turkey, partly offset by Indonesia, Poland and Ukraine); partially offset by the unfavorable impact of the Saudi Arabia customs assessments of $246 million, shown in "Cost/Other". Adjusted net revenues increased by 7.3% on an organic basis, as detailed above and in Schedule 5.

Operating income increased by 10.1%, excluding currency, primarily reflecting: favorable volume/mix, mainly driven by the same factors as for net revenues noted above; a favorable pricing variance; and lower manufacturing costs (driven by productivity gains related to reduced-risk and combustible products); partly offset by the unfavorable impact of the Saudi Arabia customs assessments (as noted above for net revenues); and higher marketing, administration and research costs, including higher asset impairment and exit costs (mainly related to organizational design optimization, as well as product distribution restructuring in South Korea) and asset acquisition costs related to OtiTopic.

Adjusted operating income increased by 14.5% on an organic basis. Adjusted operating income margin increased by 2.8 points on the same basis, as detailed in Schedule 8.

EUROPEAN UNION REGION

Third-Quarter

Financial Summary -

Quarters Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.

Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 3,192

 

$ 2,950

 

 

8.2

%

3.9

%

 

242

 

128

 

2

 

(5

)

117

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 1,680

 

$ 1,588

 

 

5.8

%

0.8

%

 

92

 

79

 

?

 

(5

)

102

 

(84

)

Asset Impairment & Exit Costs (1)

 

(12

)

?

 

 

?

%

?

%

 

(12

)

?

 

?

 

?

 

?

 

(12

)

Adjusted Operating Income

 

$ 1,692

 

$ 1,588

 

 

6.5

%

1.6

%

 

104

 

79

 

?

 

(5

)

102

 

(72

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

53.0

%

53.8

%

 

(0.8

)pp

(1.2

)pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 3.8% on an organic basis, as detailed in Schedule 5, reflecting: favorable volume/mix, mainly driven by higher heated tobacco unit volume (notably in Germany, Hungary, Italy and Poland), partly offset by lower cigarette volume (notably in France, Germany and Italy) and unfavorable cigarette mix (primarily in Germany). Pricing variance was slightly unfavorable, reflecting lower pricing for reduced-risk products (notably for heated tobacco units in Poland and devices in Germany and Italy), partly offset by higher combustible pricing (notably in Germany, partially offset by Poland).

Operating income increased by 0.8%, excluding currency, primarily reflecting: favorable volume/mix, driven by the same factors as for net revenues noted above; and lower manufacturing costs; partly offset by higher marketing, administration and research costs.

Adjusted operating income increased by 1.6% on an organic basis. Adjusted operating income margin decreased by 1.1 points on the same basis, as detailed in Schedule 8.

Nine Months Year-to-Date

Financial Summary -

Nine Months Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 9,250

 

$ 7,960

 

 

16.2

%

8.0

%

 

1,290

 

651

 

2

 

67

 

570

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 4,811

 

$ 3,924

 

 

22.6

%

12.1

%

 

887

 

413

 

?

 

67

 

507

 

(100

)

Asset Impairment & Exit Costs (1)

 

(56

)

(27

)

 

-(100

)%

-(100

)%

 

(29

)

?

 

?

 

?

 

?

 

(29

)

Adjusted Operating Income

 

$ 4,867

 

$ 3,951

 

 

23.2

%

12.7

%

 

916

 

413

 

?

 

67

 

507

 

(71

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

52.6

%

49.6

%

 

3.0

pp

2.2

pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 8.0% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher heated tobacco unit volume (notably in Germany, Hungary, Italy and Poland), partly offset by lower cigarette volume (notably in the Czech Republic, France and Germany) and unfavorable cigarette mix (primarily in Germany and Poland); and a favorable pricing variance, driven by higher combustible pricing (mainly in Germany and Portugal, partly offset by France and Poland) and higher heated tobacco unit pricing (notably in the Czech Republic, partially offset by Poland), partly offset by lower device pricing (notably in Germany and Italy).

Operating income increased by 12.1%, excluding currency, primarily reflecting: favorable volume/mix, driven by the same factors as for net revenues noted above; lower manufacturing costs (driven by combustible and reduced-risk products); and a favorable pricing variance; partly offset by higher marketing, administration and research costs (including higher asset impairment and exit costs, mainly related to organizational design optimization).

Adjusted operating income increased by 12.7% on an organic basis. Adjusted operating income margin increased by 2.2 points on the same basis, as detailed in Schedule 8.

Total Market, PMI Shipment & Market Share Commentaries

European Union Key Data

 

Third-Quarter

 

Nine Months Year-to-Date

 

 

 

 

 

 

Change

 

 

 

 

 

Change

 

 

2021

 

2020

 

% / pp

 

2021

 

2020

 

% / pp

Total Market (billion units)

 

132.4

 

132.6

 

(0.1

)%

 

360.5

 

358.1

 

0.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

PMI Shipment Volume (million units)

 

 

 

 

 

 

 

 

 

 

 

 

Cigarettes

 

41,965

 

45,179

 

(7.1

)%

 

120,238

 

126,142

 

(4.7

)%

Heated Tobacco Units

 

7,058

 

5,181

 

36.2

%

 

20,405

 

14,069

 

45.0

%

Total EU

 

49,023

 

50,360

 

(2.7

)%

 

140,643

 

140,211

 

0.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

PMI Market Share

 

 

 

 

 

 

 

 

 

 

 

 

Marlboro

 

16.5%

 

17.5%

 

(1.0

)

 

16.7%

 

17.6%

 

(0.9

)

L&M

 

5.6%

 

6.0%

 

(0.4

)

 

5.7%

 

6.3%

 

(0.6

)

Chesterfield

 

5.5%

 

5.5%

 

?

 

 

5.5%

 

5.6%

 

(0.1

)

Philip Morris

 

2.2%

 

2.5%

 

(0.3

)

 

2.2%

 

2.5%

 

(0.3

)

HEETS

 

5.3%

 

3.9%

 

1.4

 

 

5.5%

 

3.9%

 

1.6

 

Others

 

3.1%

 

3.0%

 

0.1

 

 

3.0%

 

3.0%

 

?

 

Total EU

 

38.2%

 

38.4%

 

(0.2

)

 

38.6%

 

38.9%

 

(0.3

)

Note: HEETS includes HEETS Dimensions.

Third-Quarter

The estimated total market in the EU decreased by 0.1% to 132.4 billion units, mainly due to:

partly offset by

PMI's total shipment volume decreased by 2.7% to 49.0 billion units, primarily due to:

partly offset by

Excluding the net unfavorable impact of estimated distributor inventory movements, PMI's total in-market sales volume decreased by 0.5%.

Nine Months Year-to-Date

The estimated total market in the EU increased by 0.7% to 360.5 billion units, primarily driven by:

partly offset by

PMI's total shipment volume increased by 0.3% to 140.6 billion units, primarily driven by:

partly offset by

Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales volume was essentially stable.

EASTERN EUROPE REGION

Third-Quarter

Financial Summary -

Quarters Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 941

 

$ 899

 

 

4.7

%

6.1

%

 

42

 

(13

)

?

 

22

 

33

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 338

 

$ 245

 

 

38.0

%

25.7

%

 

93

 

30

 

?

 

22

 

27

 

14

 

Asset Impairment & Exit Costs (1)

 

(2

)

?

 

 

?

%

?

%

 

(2

)

?

 

?

 

?

 

?

 

(2

)

Adjusted Operating Income

 

$ 340

 

$ 245

 

 

38.8

%

26.5

%

 

95

 

30

 

?

 

22

 

27

 

16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

36.1

%

27.3

%

 

8.8

pp

5.2

pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 6.1% on an organic basis, reflecting: favorable volume/mix, driven by higher heated tobacco unit volume (primarily in Russia and Ukraine), partly offset by unfavorable cigarette volume/mix (primarily in Russia); and a favorable pricing variance, mainly driven by higher combustible pricing (notably in Russia), partly offset by lower heated tobacco unit pricing (primarily in Ukraine, partly offset by Russia).

Operating income increased by 25.7%, excluding currency, primarily reflecting: favorable volume/mix, driven by the same factors as for net revenues noted above; a favorable pricing variance; and lower manufacturing costs (primarily related to reduced-risk products, mainly in Russia).

Adjusted operating income increased by 26.5% on an organic basis. Adjusted operating income margin increased by 5.2 points on the same basis, as detailed in Schedule 8.

Nine Months Year-to-Date

Financial Summary -

Nine Months Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 2,632

 

$ 2,470

 

 

6.6

%

9.6

%

 

162

 

(74

)

?

 

68

 

168

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 913

 

$ 610

 

 

49.7

%

50.0

%

 

303

 

(2

)

?

 

68

 

140

 

97

 

Asset Impairment & Exit Costs (1)

 

(11

)

(7

)

 

(57.1

)%

(57.1

)%

 

(4

)

?

 

?

 

?

 

?

 

(4

)

Adjusted Operating Income

 

$ 924

 

$ 617

 

 

49.8

%

50.1

%

 

307

 

(2

)

?

 

68

 

140

 

101

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

35.1

%

25.0

%

 

10.1

pp

9.2

pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 9.6% on an organic basis, reflecting: favorable volume/mix, driven by higher heated tobacco unit volume (mainly in Russia and Ukraine), partly offset by unfavorable cigarette volume (primarily in Russia and Ukraine) and unfavorable cigarette mix (mainly in Russia); and a favorable pricing variance, mainly driven by higher combustible pricing (primarily in Kazakhstan, Russia and Ukraine), partially offset by lower device pricing (mainly in Russia) and lower heated tobacco unit pricing (primarily in Ukraine, partly offset by Russia).

Operating income increased by 50.0%, excluding currency, primarily reflecting: favorable volume/mix, driven by the same factors as for net revenues noted above; lower manufacturing costs (mainly related to reduced-risk products, primarily in Russia); and a favorable pricing variance.

Adjusted operating income increased by 50.1% on an organic basis. Adjusted operating income margin increased by 9.2 points on the same basis, as detailed in Schedule 8.

Total Market, PMI Shipment & Market Share Commentaries

PMI Shipment Volume

 

Third-Quarter

 

Nine Months Year-to-Date

(million units)

 

2021

 

2020

 

Change

 

2021

 

2020

 

Change

Cigarettes

 

25,020

 

25,661

 

(2.5)%

 

67,771

 

70,737

 

(4.2)%

Heated Tobacco Units

 

6,119

 

4,882

 

25.3%

 

18,594

 

14,374

 

29.4%

Total Eastern Europe

 

31,139

 

30,543

 

2.0%

 

86,365

 

85,111

 

1.5%

Third-Quarter

The estimated total market in Eastern Europe decreased, mainly due to:

PMI's total shipment volume increased by 2.0% to 31.1 billion units, notably driven by:

partly offset by

Nine Months Year-to-Date

The estimated total market in Eastern Europe decreased, primarily due to:

PMI's total shipment volume increased by 1.5% to 86.4 billion units, notably driven by:

partly offset by

Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales volume decreased by 0.5%.

MIDDLE EAST & AFRICA REGION

Third-Quarter

Financial Summary -

Quarters Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 945

 

$ 768

 

 

23.0

%

26.6

%

 

177

 

(27

)

?

 

64

 

169

 

(29

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 388

 

$ 261

 

 

48.7

%

59.8

%

 

127

 

(29

)

?

 

64

 

135

 

(43

)

Asset Impairment & Exit Costs (1)

 

(3

)

?

 

 

?

%

?

%

 

(3

)

?

 

?

 

?

 

?

 

(3

)

Adjusted Operating Income

 

$ 391

 

$ 261

 

 

49.8

%

60.9

%

 

130

 

(29

)

?

 

64

 

135

 

(40

)

Adjusted Operating Income Margin

 

41.4

%

34.0

%

 

7.4

pp

9.2

pp

 

 

 

 

 

 

 

(1) Included in Marketing, Administration and Research Costs above.

Net revenues increased by 26.6% on an organic basis, primarily reflecting: favorable volume/mix, mainly driven by higher cigarette volume (primarily in PMI Duty Free and Turkey, partly offset by North Africa), higher heated tobacco unit volume (mainly in PMI Duty Free) and favorable cigarette mix (notably in PMI Duty Free); and a favorable pricing variance, driven by combustible pricing (mainly in Turkey); partly offset by lower fees for certain distribution rights billed to customers in certain markets, shown in "Cost/Other".

Operating income increased by 59.8%, excluding currency, mainly reflecting: favorable volume/mix, mainly driven by the same factors as for net revenues noted above; a favorable pricing variance; and lower manufacturing costs; partly offset by lower fees for certain distribution rights, as noted above for net revenues; and higher marketing, administration and research costs.

Adjusted operating income increased by 60.9% on an organic basis. Adjusted operating income margin increased by 9.2 points on the same basis, as detailed in Schedule 8.

Nine Months Year-to-Date

Financial Summary -

Nine Months Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 2,306

 

$ 2,348

 

 

(1.8

)%

1.0

%

 

(42

)

(66

)

?

 

191

 

110

 

(277

)

Saudi Arabia Customs Assessments

 

(246

)

?

 

 

?

%

?

%

 

(246

)

?

 

?

 

?

 

?

 

(246

)

Adjusted Net Revenues

 

$ 2,552

 

$ 2,348

 

 

8.7

%

11.5

%

 

204

 

(66

)

?

 

191

 

110

 

(31

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues (1)

 

$ 2,306

 

$ 2,348

 

 

(1.8

)%

1.0

%

 

(42

)

(66

)

?

 

191

 

110

 

(277

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 739

 

$ 819

 

 

(9.8

)%

(0.7

)%

 

(80

)

(74

)

?

 

191

 

70

 

(267

)

Asset Impairment & Exit Costs (2)

 

(13

)

(9

)

 

(44.4

)%

(44.4

)%

 

(4

)

?

 

?

 

?

 

?

 

(4

)

Saudi Arabia Customs Assessments (3)

 

(246

)

?

 

 

?

%

?

%

 

(246

)

?

 

?

 

?

 

?

 

(246

)

Adjusted Operating Income

 

$ 998

 

$ 828

 

 

20.5

%

29.5

%

 

170

 

(74

)

?

 

191

 

70

 

(17

)

Adjusted Operating Income Margin

 

39.1

%

35.3

%

 

3.8

pp

5.6

pp

 

 

 

 

 

 

 

(1) Cost/Other variance includes a reduction in net revenues of $246 million in 2021 related to the Saudi Arabia customs assessments.

(2) Included in Marketing, Administration and Research Costs above.

(3) Included in Net Revenues above.

Net revenues increased by 1.0%, excluding currency, despite the unfavorable impact of the Saudi Arabia customs assessments of $246 million, shown in "Cost/Other".

Adjusted net revenues increased by 11.5% on an organic basis, as detailed above and in Schedule 5, primarily reflecting: a favorable pricing variance, mainly driven by combustible pricing (mainly in Egypt and Turkey); and favorable volume/mix, primarily driven by favorable cigarette mix (mainly in PMI Duty Free, Saudi Arabia and Turkey), higher heated tobacco unit volume (mainly in Egypt, Jordan and PMI Duty Free) and higher cigarette volume (primarily in PMI Duty Free and Turkey, partly offset by Kuwait and North Africa); partially offset by lower fees for certain distribution rights billed to customers in certain markets, shown in "Cost/Other".

Operating income decreased by 0.7%, excluding currency, predominantly due to the unfavorable impact of the Saudi Arabia customs assessments, as noted above for net revenues.

Adjusted operating income increased by 29.5% on an organic basis, mainly reflecting: a favorable pricing variance; favorable volume/mix, driven by the same factors as for net revenues noted above; and lower manufacturing costs (primarily related to combustible products); partly offset by lower fees for certain distribution rights, as noted above for net revenues; and higher marketing, administration and research costs.

Adjusted operating income margin increased by 5.6 points on an organic basis, as detailed in Schedule 8.

Total Market, PMI Shipment & Market Share Commentaries

PMI Shipment Volume

 

Third-Quarter

 

Nine Months Year-to-Date

(million units)

 

2021

 

2020

 

Change

 

2021

 

2020

 

Change

Cigarettes

 

35,166

 

30,903

 

13.8%

 

93,155

 

88,087

 

5.8%

Heated Tobacco Units

 

577

 

179

 

+100%

 

1,485

 

834

 

78.1%

Total Middle East & Africa

 

35,743

 

31,082

 

15.0%

 

94,640

 

88,921

 

6.4%

Third-Quarter

The estimated total market in the Middle East & Africa increased, mainly driven by:

partly offset by

PMI's total shipment volume increased by 15.0% to 35.7 billion units, notably driven by:

partly offset by

Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales volume increased by 8.5%.

Nine Months Year-to-Date

The estimated total market in the Middle East & Africa increased, mainly driven by:

partly offset by

PMI's total shipment volume increased by 6.4% to 94.6 billion units, notably driven by:

partly offset by

SOUTH & SOUTHEAST ASIA REGION

Third-Quarter

Financial Summary -

Quarters Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 1,065

 

$ 1,071

 

 

(0.6

)%

(1.1

)%

 

(6

)

6

 

?

 

14

 

(26

)

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 348

 

$ 402

 

 

(13.4

)%

(14.4

)%

 

(54

)

4

 

?

 

14

 

(42

)

(30

)

Asset Impairment & Exit Costs (1)

 

(4

)

?

 

 

?

%

?

%

 

(4

)

?

 

?

 

?

 

?

 

(4

)

Adjusted Operating Income

 

$ 352

 

$ 402

 

 

(12.4

)%

(13.4

)%

 

(50

)

4

 

?

 

14

 

(42

)

(26

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

33.1

%

37.5

%

 

(4.4

)pp

(4.6

)pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues decreased by 1.1% on an organic basis, reflecting: unfavorable volume/mix, due to lower cigarette volume (primarily in the Philippines, partly offset by Indonesia); partially offset by a favorable pricing variance, driven by combustible pricing (mainly in the Philippines, partly offset by Indonesia).

Operating income decreased by 14.4%, excluding currency, primarily reflecting: unfavorable volume/mix, due to the same factors as for net revenues noted above; and higher manufacturing costs; partly offset by a favorable pricing variance.

Adjusted operating income decreased by 13.4% on an organic basis. Adjusted operating income margin decreased by 4.6 points on the same basis, as detailed in Schedule 8.

Nine Months Year-to-Date

Financial Summary -

Nine Months Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 3,284

 

$ 3,211

 

 

2.3

%

(0.9

)%

 

73

 

102

 

?

 

(4

)

(25

)

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 1,208

 

$ 1,290

 

 

(6.4

)%

(9.1

)%

 

(82

)

36

 

?

 

(4

)

(81

)

(33

)

Asset Impairment & Exit Costs (1)

 

(17

)

(11

)

 

(54.5

)%

(54.5

)%

 

(6

)

?

 

?

 

?

 

?

 

(6

)

Adjusted Operating Income

 

$ 1,225

 

$ 1,301

 

 

(5.8

)%

(8.6

)%

 

(76

)

36

 

?

 

(4

)

(81

)

(27

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

37.3

%

40.5

%

 

(3.2

)pp

(3.1

)pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues decreased by 0.9% on an organic basis, reflecting: unfavorable volume/mix, mainly due to lower cigarette volume (primarily the Philippines, partly offset by India and Indonesia), partially offset by favorable cigarette mix (mainly in Indonesia and the Philippines). Pricing variance was slightly unfavorable, reflecting lower pricing for combustible products (notably in Indonesia, largely offset by the Philippines).

Operating income decreased by 9.1%, excluding currency, primarily reflecting: unfavorable volume/mix, due to the same factors as for net revenues noted above; and higher marketing, administration and research costs.

Adjusted operating income decreased by 8.6% on an organic basis. Adjusted operating income margin decreased by 3.1 points on the same basis, as detailed in Schedule 8.

Total Market, PMI Shipment & Market Share Commentaries

PMI Shipment Volume

 

Third-Quarter

 

Nine Months Year-to-Date

(million units)

 

2021

 

2020

 

Change

 

2021

 

2020

 

Change

Cigarettes

 

35,578

 

37,238

 

(4.5)%

 

105,787

 

108,179

 

(2.2)%

Heated Tobacco Units

 

79

 

10

 

+100%

 

151

 

10

 

+100%

Total South & Southeast Asia

 

35,657

 

37,248

 

(4.3)%

 

105,938

 

108,189

 

(2.1)%

Third-Quarter

The estimated total market in South & Southeast Asia increased, mainly driven by:

partly offset by

PMI's total shipment volume decreased by 4.3% to 35.7 billion units, mainly due to:

partly offset by

Nine Months Year-to-Date

The estimated total market in South & Southeast Asia increased, mainly driven by:

partly offset by:

PMI's total shipment volume decreased by 2.1% to 105.9 billion units, notably due to:

partly offset by:

EAST ASIA & AUSTRALIA REGION

Third-Quarter

Financial Summary -

Quarters Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 1,523

 

$ 1,358

 

 

12.2

%

12.7

%

 

165

 

(7

)

?

 

47

 

125

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 631

 

$ 637

 

 

(0.9

)%

2.7

%

 

(6

)

(23

)

?

 

47

 

3

 

(33

)

Asset Impairment & Exit Costs (1)

 

(21

)

?

 

 

?

%

?

%

 

(21

)

?

 

?

 

?

 

?

 

(21

)

Adjusted Operating Income

 

$ 652

 

$ 637

 

 

2.4

%

6.0

%

 

15

 

(23

)

?

 

47

 

3

 

(12

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

42.8

%

46.9

%

 

(4.1

)pp

(2.8

)pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 12.7% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher heated tobacco unit volume and favorable device volume/mix (predominantly in Japan, driven by the launch of IQOS ILUMA), partly offset by unfavorable cigarette mix (primarily in Japan) and lower cigarette volume (particularly in Australia, partly offset by Japan); and a favorable pricing variance, primarily driven by higher heated tobacco, combustible and device pricing in Japan.

Operating income increased by 2.7%, excluding currency, mainly reflecting: a favorable pricing variance; and lower manufacturing costs (primarily related to reduced-risk products in Japan); partly offset by higher marketing, administration and research costs (notably due to the launch of IQOS ILUMA in Japan and higher asset impairment and exit costs, mainly related to product distribution restructuring in South Korea). Volume/mix was slightly favorable, notably reflecting higher heated tobacco unit and cigarette volume in Japan, largely offset by lower cigarette volume in Australia and unfavorable cigarette mix in Japan.

Adjusted operating income increased by 6.0% on an organic basis. Adjusted operating income margin decreased by 2.8 points on the same basis, as detailed in Schedule 8.

Nine Months Year-to-Date

Financial Summary -

Nine Months Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.

Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 4,509

 

$ 4,045

 

 

11.5

%

9.0

%

 

464

 

101

 

?

 

240

 

123

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 2,041

 

$ 1,792

 

 

13.9

%

14.2

%

 

249

 

(6

)

?

 

240

 

21

 

(6

)

Asset Impairment & Exit Costs (1)

 

(67

)

(13

)

 

-(100

)%

-(100

)%

 

(54

)

?

 

?

 

?

 

?

 

(54

)

Adjusted Operating Income

 

$ 2,108

 

$ 1,805

 

 

16.8

%

17.1

%

 

303

 

(6

)

?

 

240

 

21

 

48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

46.8

%

44.6

%

 

2.2

pp

3.4

pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 9.0% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher heated tobacco and combustible pricing in Japan, partly offset by lower combustible pricing in Australia; and favorable volume/mix, mainly driven by higher heated tobacco unit volume and favorable device volume/mix in Japan (driven by the launch of IQOS ILUMA), partly offset by lower cigarette volume (primarily in Australia, Japan and South Korea) and unfavorable cigarette mix (mainly in Australia and Japan).

Operating income increased by 14.2%, excluding currency, mainly reflecting: a favorable pricing variance; lower manufacturing costs (primarily related to reduced-risk products in Japan); and favorable volume/mix, driven by higher heated tobacco unit volume in Japan, partly offset by lower cigarette volume (primarily in Australia, Japan and South Korea), unfavorable cigarette mix (mainly in Australia and Japan) and unfavorable heated tobacco unit mix in Japan; partially offset by higher marketing, administration and research costs (notably reflecting the same factors as in the quarter).

Adjusted operating income increased by 17.1%, on an organic basis. Adjusted operating income margin increased by 3.4 points on the same basis, as detailed in Schedule 8.

Total Market, PMI Shipment & Market Share Commentaries

PMI Shipment Volume

 

Third-Quarter

 

Nine Months Year-to-Date

(million units)

 

2021

 

2020

 

Change

 

2021

 

2020

 

Change

Cigarettes

 

11,120

 

10,784

 

3.1%

 

33,450

 

35,154

 

(4.8)%

Heated Tobacco Units

 

9,435

 

8,601

 

9.7%

 

28,478

 

24,799

 

14.8%

Total East Asia & Australia

 

20,555

 

19,385

 

6.0%

 

61,928

 

59,953

 

3.3%

Third-Quarter

The estimated total market in East Asia & Australia, excluding China, decreased, primarily due to:

PMI's total shipment volume increased by 6.0% to 20.6 billion units, mainly driven by:

partly offset by

Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales volume declined by 1.7%.

Nine Months Year-to-Date

The estimated total market in East Asia & Australia, excluding China, decreased, mainly due to:

PMI's total shipment volume increased by 3.3% to 61.9 billion units, mainly driven by:

partly offset by

Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales volume declined by 0.6%.

AMERICAS REGION

Third-Quarter

Financial Summary -

Quarters Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 456

 

$ 400

 

 

14.0

%

9.0

%

 

56

 

20

 

?

 

16

 

21

 

(1

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 121

 

$ 110

 

 

10.0

%

6.4

%

 

11

 

4

 

?

 

16

 

3

 

(12

)

Asset Impairment & Exit Costs (1)

 

(1

)

?

 

 

?

%

?

%

 

(1

)

?

 

?

 

?

 

?

 

(1

)

Adjusted Operating Income

 

$ 122

 

$ 110

 

 

10.9

%

7.3

%

 

12

 

4

 

?

 

16

 

3

 

(11

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

26.8

%

27.5

%

 

(0.7

)pp

(0.4

)pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 9.0% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher cigarette volume (primarily in Colombia and Mexico) and higher device volume (notably in Canada); and a favorable pricing variance driven by combustible products (notably in Argentina and Mexico).

Operating income increased by 6.4%, excluding currency, primarily reflecting: a favorable pricing variance; partly offset by higher manufacturing costs; and higher marketing, administration and research costs.

Adjusted operating income increased by 7.3% on an organic basis. Adjusted operating income margin decreased by 0.4 points on the same basis, as detailed in Schedule 8.

Nine Months Year-to-Date

Financial Summary -

Nine Months Ended September 30,

 

 

 

 

Change

Fav./(Unfav.)

 

Variance

Fav./(Unfav.)

 

2021

2020

 

Total

Excl.
Curr.

 

Total

Cur-
rency

Acqui-
sitions

Price

Vol/
Mix

Cost/
Other

(in millions)

 

 

 

Net Revenues

 

$ 1,320

 

$ 1,216

 

 

8.6

%

5.4

%

 

104

 

38

 

?

 

28

 

37

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

$ 367

 

$ 328

 

 

11.9

%

8.2

%

 

39

 

12

 

?

 

28

 

(3

)

2

 

Asset Impairment & Exit Costs (1)

 

(6

)

(4

)

 

(50.0

)%

(50.0

)%

 

(2

)

?

 

?

 

?

 

?

 

(2

)

Adjusted Operating Income

 

$ 373

 

$ 332

 

 

12.3

%

8.7

%

 

41

 

12

 

?

 

28

 

(3

)

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Operating Income Margin

 

28.3

%

27.3

%

 

1.0

pp

0.9

pp

 

 

 

 

 

 

 

(1) Included in marketing, administration and research costs at the consolidated operating income level.

Net revenues increased by 5.4% on an organic basis, mainly reflecting: favorable volume/mix, primarily driven by higher cigarette volume (mainly in Brazil and Mexico) and higher device volume (notably in Canada); and a favorable pricing variance, driven by higher combustible pricing (notably in Argentina and Colombia).

Operating income increased by 8.2%, excluding currency, primarily reflecting: a favorable pricing variance; and lower marketing, administration and research costs; partly offset by higher manufacturing costs.

Adjusted operating income increased by 8.7% on an organic basis. Adjusted operating income margin increased by 0.9 points on the same basis, as detailed in Schedule 8.

Total Market, PMI Shipment & Market Share Commentaries

PMI Shipment Volume

 

Third-Quarter

 

Nine Months Year-to-Date

(million units)

 

2021

 

2020

 

Change

 

2021

 

2020

 

Change

Cigarettes

 

15,994

 

15,699

 

1.9%

 

46,092

 

45,542

 

1.2%

Heated Tobacco Units

 

221

 

114

 

93.9%

 

466

 

316

 

47.5%

Total Americas

 

16,215

 

15,813

 

2.5%

 

46,558

 

45,858

 

1.5%

Third-Quarter

The estimated total market in Americas decreased, notably due to:

partly offset by

PMI's total shipment volume increased by 2.5% to 16.2 billion units, notably driven by:

partly offset by

Nine Months Year-to-Date

The estimated total market in Americas increased, mainly driven by:

partly offset by

PMI's total shipment volume increased by 1.5% to 46.6 billion units, primarily driven by:

partly offset by

OTHER

Third-Quarter and Nine Months Year-to-Date

Following the acquisitions of Fertin Pharma A/S, OtiTopic, Inc. and Vectura Group plc., PMI added the "Other" category in the third quarter of 2021. Business operations for the Other category are evaluated separately from the geographical operating segments.

Due to the timing of the Fertin Pharma and Vectura acquisitions, the company did not record the immaterial results of operations from these two acquisitions in its consolidated statements of earnings from the acquisition dates through September 30, 2021.

PMI accounted for the OtiTopic transaction as an asset acquisition since the in-process research and development of the dry power inhalation aspirin treatment represented substantially all of the fair value of the gross assets acquired and had no alternative future use. As a result, PMI recorded a pre-tax charge of $51 million to research and development costs within marketing, administration and research costs of the Other category for the third quarter and the nine months year-to-date. The charge has been excluded from adjusted results.

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders and other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, versions of PMI's IQOS Platform 1 device and consumables have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product portfolio includes heat-not-burn, nicotine-containing vapor products and oral nicotine products. As of September 30, 2021, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 14.9 million adults around the world have already switched to IQOS and stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.

Forward-Looking and Cautionary Statements

This press release contains projections of future results and other forward-looking statements. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.

PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; changes in adult smoker behavior; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; or if it is unable to attract and retain the best global talent. Future results are also subject to the lower predictability of our reduced-risk product category's performance.

In addition, PMI's business risks also include risks and uncertainties related to PMI's acquisitions of Fertin Pharma A/S ("Fertin"), OtiTopic, Inc. ("OtiTopic") and Vectura Group plc ("Vectura"), including, amongst other things: (1) the possibility that the integration of the operations of Fertin and Vectura with those of PMI may be more difficult and/or take longer than anticipated, and may not accelerate PMI's desired entry into additional smoke-free and beyond nicotine platforms as quickly as anticipated; (2) the possibility that the respective integrations of Fertin and Vectura into PMI may be more costly than anticipated and may have unanticipated adverse results relating to Fertin, Vectura or PMI's existing businesses; (3) the inability to gain access to or acquire differentiated proprietary assets, technology and/or pharmaceutical development expertise as anticipated by these acquisitions; (4) risks associated with third-party contracts containing consent and/or other contractual provisions that may be triggered by the acquisitions; (5) the success of the research and development efforts of Fertin, OtiTopic and Vectura, including the ability to obtain regulatory approval for new products, and the ability to commercialize or license these new products; (6) any unanticipated safety, quality or efficacy concerns and the impact of identified concerns associated with the products developed by Fertin, OtiTopic and Vectura; and (7) the ability of PMI to retain key personnel of Fertin and Vectura, or hire key talent to work in the Fertin and Vectura businesses due to their affiliation with PMI.

The COVID-19 pandemic has created significant societal and economic disruption, and resulted in closures of stores, factories and offices, and restrictions on manufacturing, distribution and travel, all of which will adversely impact our business, results of operations, cash flows and financial position during the continuation of the pandemic. Our business continuity plans and other safeguards may not be effective to mitigate the impact of the pandemic. Currently, significant risks include our diminished ability to convert adult smokers to our reduced-risk products, significant volume declines in our duty-free business and certain other key markets, disruptions or delays in our manufacturing and supply chain, increased currency volatility, and delays in certain cost saving, transformation and restructuring initiatives. Our business could also be adversely impacted if key personnel or a significant number of employees or business partners become unavailable due to the continuation of the COVID-19 pandemic. The significant adverse impact of COVID-19 on the economic or political conditions in markets in which we operate could result in changes to the preferences of our adult consumers and lower demand for our products, particularly for our mid-price or premium-price brands. Continuation of the pandemic could disrupt our access to the credit markets or increase our borrowing costs. Governments may temporarily be unable to focus on the development of science-based regulatory frameworks for the development and commercialization of reduced-risk products or on the enforcement or implementation of regulations that are significant to our business. In addition, messaging about the potential negative impacts of the use of our products on COVID-19 risks may lead to increasingly restrictive regulatory measures on the sale and use of our products, negatively impact demand for our products, the willingness of adult consumers to switch to our reduced-risk products and our efforts to advocate for the development of science-based regulatory frameworks for the development and commercialization of reduced-risk products.

The impact of these risks also depends on factors beyond our knowledge or control, including the duration and severity of the pandemic, its recurrence in our key markets, actions taken to contain its spread and to mitigate its public health effects, and the ultimate economic consequences thereof.

PMI is further subject to other risks detailed from time to time in its publicly filed documents, including the Form 10-Q for the quarter ended June 30, 2021. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.

Key Terms, Definitions and Explanatory Notes

General

Financial

Reduced-Risk Products

Note: as of December 2020, PMI heat-not-burn products and HTUs include licensed KT&G heat-not-burn products and HTUs, respectively.

IQOS in the United States

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Appendix 1

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Key Market Data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarters Ended September 30,

Market

 

Total Market,

bio units

 

PMI Shipments, bio units

 

PMI Market Share, % (1)

 

 

Total

 

Cigarette

 

HTU

 

Total

 

HTU

 

2021

2020

%
Change

 

2021

2020

%
Change

 

2021

2020

%
Change

 

2021

2020

%
Change

 

2021

2020

pp
Change

 

2021

2020

pp
Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

679.6

 

674.3

 

0.8

 

 

188.3

 

184.4

 

2.1

 

 

164.8

 

165.5

 

(0.4

)

 

23.5

 

19.0

 

23.8

 

 

28.0

 

28.0

 

?

 

 

3.6

 

3.0

 

0.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

European Union

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

France

 

9.0

 

9.8

 

(8.0

)

 

3.7

 

4.2

 

(10.8

)

 

3.6

 

4.1

 

(11.7

)

 

0.1

 

?

 

?

 

 

44.0

 

45.3

 

(1.3

)

 

0.6

 

0.5

 

0.1

 

Germany

 

20.5

 

20.4

 

0.7

 

 

7.3

 

7.4

 

(1.1

)

 

6.8

 

7.0

 

(3.8

)

 

0.6

 

0.4

 

50.0

 

 

35.8

 

36.4

 

(0.6

)

 

2.8

 

1.9

 

0.9

 

Italy

 

19.2

 

18.8

 

2.1

 

 

9.4

 

9.7

 

(3.1

)

 

7.3

 

8.2

 

(11.1

)

 

2.1

 

1.5

 

41.0

 

 

52.9

 

52.1

 

0.8

 

 

10.8

 

7.8

 

3.0

 

Poland

 

14.0

 

13.5

 

3.4

 

 

5.3

 

5.1

 

3.8

 

 

4.5

 

4.5

 

(0.3

)

 

0.8

 

0.6

 

32.7

 

 

38.0

 

37.8

 

0.2

 

 

6.0

 

4.7

 

1.3

 

Spain

 

12.1

 

11.7

 

3.1

 

 

3.4

 

3.7

 

(9.1

)

 

3.2

 

3.6

 

(10.1

)

 

0.1

 

0.1

 

25.3

 

 

32.1

 

32.2

 

(0.1

)

 

1.1

 

0.9

 

0.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Eastern Europe

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Russia

 

59.3

 

59.8

 

(0.9

)

 

18.8

 

18.6

 

0.7

 

 

15.0

 

15.5

 

(3.8

)

 

3.8

 

3.1

 

23.3

 

 

32.0

 

31.8

 

0.2

 

 

6.9

 

5.8

 

1.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Middle East & Africa

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Saudi Arabia

 

5.4

 

5.5

 

(1.6

)

 

2.3

 

2.4

 

(4.2

)

 

2.3

 

2.4

 

(5.0

)

 

?

 

?

 

?

 

 

40.8

 

36.9

 

3.9

 

 

1.1

 

0.4

 

0.7

 

Turkey

 

 

36.1

 

32.1

 

12.5

 

 

16.0

 

13.5

 

18.4

 

 

16.0

 

13.5

 

18.4

 

 

?

 

?

 

?

 

 

44.2

 

42.0

 

2.2

 

 

?

 

?

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

South & Southeast Asia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Indonesia

 

74.3

 

70.1

 

6.0

 

 

20.8

 

19.8

 

5.1

 

 

20.8

 

19.8

 

5.1

 

 

?

 

?

 

?

 

 

28.0

 

28.2

 

(0.2

)

 

?

 

?

 

?

 

Philippines

 

14.4

 

17.5

 

(17.7

)

 

8.9

 

11.7

 

(23.8

)

 

8.9

 

11.7

 

(24.1

)

 

?

 

?

 

?

 

 

61.9

 

66.8

 

(4.9

)

 

0.3

 

?

 

0.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

East Asia & Australia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Australia

 

2.3

 

3.2

 

(28.0

)

 

0.8

 

1.0

 

(19.0

)

 

0.8

 

1.0

 

(19.0

)

 

?

 

?

 

?

 

 

33.7

 

29.8

 

3.9

 

 

?

 

?

 

?

 

Japan

 

39.7

 

40.8

 

(2.8

)

 

13.6

 

11.9

 

14.6

 

 

5.4

 

4.6

 

18.4

 

 

8.2

 

7.3

 

12.2

 

 

38.3

 

36.9

 

1.4

 

 

22.9

 

20.4

 

2.5

 

South Korea

 

19.2

 

20.2

 

(5.2

)

 

3.7

 

3.9

 

(5.9

)

 

2.5

 

2.7

 

(7.1

)

 

1.2

 

1.2

 

(3.2

)

 

19.2

 

19.5

 

(0.3

)

 

6.1

 

6.0

 

0.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Americas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Argentina

 

8.4

 

8.6

 

(2.1

)

 

4.8

 

4.9

 

(2.5

)

 

4.8

 

4.9

 

(2.5

)

 

?

 

?

 

?

 

 

56.6

 

56.8

 

(0.2

)

 

?

 

?

 

?

 

Mexico

 

7.8

 

7.7

 

0.8

 

 

5.0

 

4.8

 

3.9

 

 

5.0

 

4.8

 

3.8

 

 

?

 

?

 

?

 

 

64.6

 

62.7

 

1.9

 

 

0.3

 

0.2

 

0.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Market share estimates are calculated using IMS data

Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Appendix 2

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Key Market Data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

Market

 

Total Market,

bio units

 

PMI Shipments, bio units

 

PMI Market Share, % (1)

 

 

Total

 

Cigarette

 

HTU

 

Total

 

HTU

 

2021

2020

%
Change

 

2021

2020

%
Change

 

2021

2020

%
Change

 

2021

2020

%
Change

 

2021

2020

pp
Change

 

2021

2020

pp
Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

1,946.1

 

1,897.3

 

2.6

 

 

536.1

 

528.2

 

1.5

 

 

466.5

 

473.8

 

(1.6

)

 

69.6

 

54.4

 

27.9

 

 

27.3

 

27.9

 

(0.6

)

 

3.5

 

2.9

 

0.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

European Union

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

France

 

26.3

 

28.0

 

(6.1

)

 

11.6

 

12.7

 

(8.3

)

 

11.4

 

12.5

 

(8.8

)

 

0.2

 

0.1

 

36.9

 

 

43.7

 

44.9

 

(1.2

)

 

0.6

 

0.5

 

0.1

 

Germany

 

56.5

 

56.4

 

0.1

 

 

21.6

 

22.0

 

(1.4

)

 

20.0

 

20.8

 

(4.0

)

 

1.7

 

1.2

 

44.2

 

 

38.3

 

38.9

 

(0.6

)

 

3.0

 

2.1

 

0.9

 

Italy

 

53.0

 

50.8

 

4.2

 

 

28.9

 

26.7

 

8.1

 

 

22.4

 

22.8

 

(1.5

)

 

6.5

 

4.0

 

62.8

 

 

52.9

 

52.0

 

0.9

 

 

11.1

 

7.6

 

3.5

 

Poland

 

37.2

 

35.0

 

6.4

 

 

13.9

 

13.6

 

2.3

 

 

11.7

 

12.1

 

(2.7

)

 

2.2

 

1.6

 

40.9

 

 

37.4

 

38.9

 

(1.5

)

 

5.9

 

4.5

 

1.4

 

Spain

 

32.2

 

31.7

 

1.4

 

 

10.2

 

10.1

 

1.1

 

 

9.8

 

9.8

 

0.5

 

 

0.4

 

0.3

 

18.0

 

 

31.5

 

31.5

 

?

 

 

1.2

 

1.0

 

0.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Eastern Europe

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Russia

 

 

163.7

 

163.4

 

0.2

 

 

52.0

 

51.6

 

0.9

 

 

40.4

 

42.3

 

(4.5

)

 

11.7

 

9.3

 

25.3

 

 

31.5

 

32.3

 

(0.8

)

 

7.2

 

6.1

 

1.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Middle East & Africa

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Saudi Arabia

 

16.2

 

15.8

 

2.0

 

 

6.6

 

6.2

 

5.3

 

 

6.4

 

6.2

 

3.5

 

 

0.2

 

?

 

?

 

 

41.5

 

38.5

 

3.0

 

 

0.9

 

0.2

 

0.7

 

Turkey

 

 

92.1

 

86.4

 

6.6

 

 

40.4

 

35.3

 

14.6

 

 

40.4

 

35.3

 

14.6

 

 

?

 

?

 

?

 

 

43.9

 

40.8

 

3.1

 

 

?

 

?

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

South & Southeast Asia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Indonesia

 

217.4

 

201.4

 

7.9

 

 

60.8

 

58.3

 

4.3

 

 

60.8

 

58.3

 

4.3

 

 

?

 

?

 

?

 

 

28.0

 

28.9

 

(0.9

)

 

?

 

?

 

?

 

Philippines

 

41.2

 

47.0

 

(12.3

)

 

25.6

 

32.1

 

(20.3

)

 

25.5

 

32.1

 

(20.6

)

 

0.1

 

?

 

?

 

 

62.2

 

68.4

 

(6.2

)

 

0.3

 

?

 

0.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

East Asia & Australia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Australia

 

7.1

 

8.3

 

(14.5

)

 

2.3

 

2.5

 

(6.4

)

 

2.3

 

2.5

 

(6.4

)

 

?

 

?

 

?

 

 

32.4

 

29.6

 

2.8

 

 

?

 

?

 

?

 

Japan

 

107.3

 

111.4

 

(3.7

)

 

41.6

 

38.8

 

7.2

 

 

16.8

 

17.7

 

(4.9

)

 

24.7

 

21.1

 

17.3

 

 

38.6

 

36.7

 

1.9

 

 

23.0

 

20.0

 

3.0

 

South Korea

 

54.1

 

54.8

 

(1.4

)

 

10.7

 

11.3

 

(5.3

)

 

7.2

 

7.8

 

(7.6

)

 

3.5

 

3.5

 

(0.3

)

 

19.7

 

20.7

 

(1.0

)

 

6.4

 

6.4

 

?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Americas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Argentina

 

26.1

 

24.3

 

7.5

 

 

14.6

 

14.9

 

(2.4

)

 

14.6

 

14.9

 

(2.4

)

 

?

 

?

 

?

 

 

55.8

 

61.5

 

(5.7

)

 

?

 

?

 

?

 

Mexico

 

22.6

 

21.9

 

3.0

 

 

14.1

 

13.6

 

3.9

 

 

14.1

 

13.6

 

3.7

 

 

0.1

 

?

 

?

 

 

62.5

 

62.0

 

0.5

 

 

0.3

 

0.2

 

0.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Market share estimates are calculated using IMS data

Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

 

 

 

 

 

 

Schedule 1

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Diluted Earnings Per Share (EPS)

($ in millions, except per share data) / (Unaudited)

 

 

 

 

 

 

 

 

 

Quarters Ended

Diluted EPS

Nine Months Ended

September 30,

September 30,

$

1.55

 

2021 Diluted Earnings Per Share (1)

$

4.48

 

 

$

1.48

 

2020 Diluted Earnings Per Share (1)

$

3.90

 

 

$

0.07

 

Change

$

0.58

 

 

4.7

%

% Change

14.9

%

 

 

 

 

 

 

Reconciliation:

 

 

$

1.48

 

2020 Diluted Earnings Per Share (1)

$

3.90

 

 

?

 

2020 Asset impairment and exit costs

0.04

 

 

?

 

2020 Fair value adjustment for equity security investments

0.04

 

 

(0.06

)

2020 Tax items

(0.06

)

 

(0.02

)

2021 Asset impairment and exit costs

(0.09

)

 

?

 

2021 Saudi Arabia customs assessments

(0.14

)

 

(0.03

)

2021 Asset acquisition cost

(0.03

)

 

0.02

 

2021 Equity investee ownership dilution

0.02

 

 

?

 

2021 Tax items

?

 

 

0.04

 

Currency

0.18

 

 

0.01

 

Interest

(0.01

)

 

0.04

 

Change in tax rate

0.07

 

 

0.07

 

Operations (2)

0.56

 

 

$

1.55

 

2021 Diluted Earnings Per Share (1)

$

4.48

 

 

 

 

 

 

 

 

 

 

 

(1) Basic and diluted EPS were calculated using the following (in millions):

 

 

 

 

 

 

 

 

 

Quarters Ended

 

Nine Months Ended

September 30,

 

September 30,

2021

 

2020

 

2021

 

2020

$ 2,426

 

$ 2,307

Net Earnings attributable to PMI

$ 7,016

 

$ 6,080

7

 

5

Less: Distributed and undistributed earnings
attributable to share-based payment awards

21

 

15

$ 2,419

 

$ 2,302

Net Earnings for basic and diluted EPS

$ 6,995

 

$ 6,065

 

 

 

 

 

 

 

1,558

 

1,558

Weighted-average shares for basic EPS

1,558

 

1,557

2

 

?

Plus Contingently Issuable Performance Stock Units

2

 

?

1,560

 

1,558

Weighted-average shares for diluted EPS

1,560

 

1,557

 

 

 

 

 

 

 

 

 

(2) Includes the impact of shares outstanding and share-based payments

 

 

 

 

 

 

 

 

 

Schedule 2

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Reconciliation of Reported Diluted EPS to Reported Diluted EPS, excluding Currency,

and Reconciliation of Reported Diluted EPS to Adjusted Diluted EPS, excluding Currency

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Quarters Ended September 30,

 

 

 

Nine Months Ended September 30,

 

 

 

2021

 

2020

 

% Change

 

 

 

2021

 

2020

 

% Change

 

 

 

$ 1.55

 

$ 1.48

 

4.7

%

 

Reported Diluted EPS

 

$ 4.48

 

$ 3.90

 

14.9

%

 

 

 

0.04

 

 

 

 

Less: Currency

 

0.18

 

 

 

 

 

 

$ 1.51

 

$ 1.48

 

2.0

%

 

Reported Diluted EPS, excluding Currency

 

$ 4.30

 

$ 3.90

 

10.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarters Ended September 30,

 

 

 

Nine Months Ended September 30,

 

 

Year Ended

2021

 

2020

 

% Change

 

 

 

2021

 

2020

 

% Change

 

 

2020

$ 1.55

 

$ 1.48

 

4.7

%

 

Reported Diluted EPS

 

$ 4.48

 

$ 3.90

 

14.9

%

 

 

$ 5.16

 

?

 

?

 

 

 

Saudi Arabia customs assessments

 

0.14

 

?

 

 

 

 

?

 

0.02

 

?

 

 

 

Asset impairment and exit costs

 

0.09

 

0.04

 

 

 

 

0.08

 

0.03

 

?

 

 

 

Asset acquisition cost

 

0.03

 

?

 

 

 

 

?

 

(0.02

)

?

 

 

 

Equity investee ownership dilution

 

(0.02

)

?

 

 

 

 

?

 

?

 

?

 

 

 

Fair value adjustment for equity security investments

 

?

 

0.04

 

 

 

 

0.04

 

?

 

(0.06

)

 

 

Tax items

 

?

 

(0.06

)

 

 

 

(0.06

)

?

 

?

 

 

 

Brazil indirect tax credit

 

?

 

?

 

 

 

 

(0.05

)

$ 1.58

 

$ 1.42

 

11.3

%

 

Adjusted Diluted EPS

 

$ 4.72

 

$ 3.92

 

20.4

%

 

 

$ 5.17

 

0.04

 

 

 

 

Less: Currency

 

0.18

 

 

 

 

 

 

$ 1.54

 

$ 1.42

 

8.5

%

 

Adjusted Diluted EPS, excluding Currency

 

$ 4.54

 

$ 3.92

 

15.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 3

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Net Revenues by Product Category and Adjustments of Net Revenues for the Impact of Currency and Acquisitions

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net
Revenues

Currency

Net
Revenues
excluding
Currency

Acquisitions

Net
Revenues
excluding
Currency &
Acquisitions

 

Quarters Ended
September 30,

 

Net
Revenues

 

Total

Excluding
Currency

Excluding
Currency &
Acquisitions

2021

 

Combustible Products

 

2020

 

% Change

$ 2,170

$ 88

$ 2,082

$ ?

$ 2,082

 

European Union

 

$ 2,244

 

(3.3)%

(7.2)%

(7.2)%

635

(7)

641

?

641

 

Eastern Europe

 

636

 

(0.2)%

0.9%

0.9%

901

(28)

928

?

928

 

Middle East & Africa

 

768

 

17.3%

20.8%

20.8%

1,061

6

1,055

?

1,055

 

South & Southeast Asia

 

1,071

 

(0.9)%

(1.5)%

(1.5)%

591

4

587

?

587

 

East Asia & Australia

 

605

 

(2.2)%

(2.9)%

(2.9)%

438

19

418

?

418

 

Americas

 

393

 

11.4%

6.5%

6.5%

$ 5,796

$ 83

$ 5,713

$ ?

$ 5,713

 

Total Combustible

 

$ 5,716

 

1.4%

(0.1)%

(0.1)%

2021

 

Reduced-Risk Products

 

2020

 

% Change

$ 1,022

$ 40

$ 982

$ 2

$ 979

 

European Union

 

$ 706

 

44.7%

39.0%

38.7%

306

(6)

313

?

313

 

Eastern Europe

 

263

 

16.4%

18.8%

18.8%

44

1

44

?

44

 

Middle East & Africa

 

?

 

?%

?%

?%

4

?

4

?

4

 

South & Southeast Asia

 

?

 

?%

?%

?%

932

(11)

943

?

943

 

East Asia & Australia

 

753

 

23.7%

25.1%

25.1%

18

1

18

?

18

 

Americas

 

7

 

+100%

+100%

+100%

$ 2,326

$ 24

$ 2,302

$ 2

$ 2,300

 

Total RRPs

 

$ 1,730

 

34.5%

33.1%

33.0%

2021

 

PMI

 

2020

 

% Change

$ 3,192

$ 128

$ 3,064

$ 2

$ 3,062

 

European Union

 

$ 2,950

 

8.2%

3.9%

3.8%

941

(13)

954

?

954

 

Eastern Europe

 

899

 

4.7%

6.1%

6.1%

945

(27)

972

?

972

 

Middle East & Africa

 

768

 

23.0%

26.6%

26.6%

1,065

6

1,059

?

1,059

 

South & Southeast Asia

 

1,071

 

(0.6)%

(1.1)%

(1.1)%

1,523

(7)

1,530

?

1,530

 

East Asia & Australia

 

1,358

 

12.2%

12.7%

12.7%

456

20

436

?

436

 

Americas

 

400

 

14.0%

9.0%

9.0%

$ 8,122

$ 107

$ 8,015

$ 2

$ 8,013

 

Total PMI

 

$ 7,446

 

9.1%

7.6%

7.6%

 

 

 

 

 

 

 

 

 

 

 

 

 

Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. "-" indicates amounts between -$0.5 million and +$0.5 million

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 4

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Net Revenues by Product Category and Adjustments of Net Revenues for the Impact of Currency and Acquisitions

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net
Revenues

Currency

Net
Revenues
excluding
Currency

Acquisitions

Net
Revenues
excluding
Currency &
Acquisitions

 

Nine Months Ended

September 30,

 

Net
Revenues

 

Total

Excluding
Currency

Excluding
Currency &
Acquisitions

2021

 

Combustible Products

 

2020

 

% Change

$ 6,283

 

$ 445

$ 5,838

$ ?

$ 5,838

 

European Union

 

$ 6,099

 

3.0%

(4.3)%

(4.3)%

1,681

 

(29)

1,710

?

1,710

 

Eastern Europe

 

1,681

 

?%

1.7%

1.7%

2,208

(1)

(67)

2,275

?

2,275

 

Middle East & Africa

 

2,296

 

(3.9)%

(0.9)%

(0.9)%

3,277

 

102

3,175

?

3,175

 

South & Southeast Asia

 

3,211

 

2.1%

(1.1)%

(1.1)%

1,850

 

65

1,786

?

1,786

 

East Asia & Australia

 

1,876

 

(1.4)%

(4.8)%

(4.8)%

1,278

 

37

1,241

?

1,241

 

Americas

 

1,196

 

6.9%

3.8%

3.8%

$ 16,577

 

$ 552

$ 16,025

$ ?

$ 16,025

 

Total Combustible

 

$ 16,360

 

1.3%

(2.0)%

(2.0)%

2021

 

Reduced-Risk Products

 

2020

 

% Change

$ 2,967

 

$ 206

$ 2,761

$ 2

$ 2,759

 

European Union

 

$ 1,861

 

59.5%

48.4%

48.3%

951

 

(45)

996

?

996

 

Eastern Europe

 

789

 

20.5%

26.2%

26.2%

98

 

1

97

?

97

 

Middle East & Africa

 

52

 

90.2%

87.7%

87.7%

7

 

?

7

?

7

 

South & Southeast Asia

 

?

 

?%

?%

?%

2,659

 

36

2,622

?

2,622

 

East Asia & Australia

 

2,169

 

22.6%

20.9%

20.9%

42

 

1

41

?

41

 

Americas

 

20

 

+100%

+100%

+100%

$ 6,724

 

$ 200

$ 6,524

$ 2

$ 6,522

 

Total RRPs

 

$ 4,890

 

37.5%

33.4%

33.4%

2021

 

PMI

 

2020

 

% Change

$ 9,250

 

$ 651

$ 8,599

$ 2

$ 8,597

 

European Union

 

$ 7,960

 

16.2%

8.0%

8.0%

2,632

 

(74)

2,706

?

2,706

 

Eastern Europe

 

2,470

 

6.6%

9.6%

9.6%

2,306

(1)

(66)

2,372

?

2,372

 

Middle East & Africa

 

2,348

 

(1.8)%

1.0%

1.0%

3,284

 

102

3,182

?

3,182

 

South & Southeast Asia

 

3,211

 

2.3%

(0.9)%

(0.9)%

4,509

 

101

4,408

?

4,408

 

East Asia & Australia

 

4,045

 

11.5%

9.0%

9.0%

1,320

 

38

1,282

?

1,282

 

Americas

 

1,216

 

8.6%

5.4%

5.4%

$ 23,301

 

$ 752

$ 22,549

$ 2

$ 22,547

 

Total PMI

 

$ 21,250

 

9.7%

6.1%

6.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments

Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. "-" indicates amounts between -$0.5 million and +$0.5 million

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 5

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Reconciliation of Net Revenues to Adjusted Net Revenues, excluding Currency and Acquisitions

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net
Revenues

Special
Items

Adjusted
Net
Revenues

Currency

Adjusted
Net
Revenues
excluding
Currency

Acqui-
sitions

Adjusted
Net
Revenues
excluding
Currency
& Acqui-
sitions

 

 

 

Net
Revenues

Special
Items

Adjusted
Net
Revenues

 

Total

Excluding
Currency

Excluding
Currency
& Acqui-
sitions

2021

 

Quarters Ended

September 30,

 

2020

 

% Change

$ 3,192

$ ?

 

$ 3,192

$ 128

$ 3,064

$ 2

$ 3,062

 

European Union

 

$ 2,950

$ ?

$ 2,950

 

8.2%

3.9%

3.8%

941

?

 

941

(13)

954

?

954

 

Eastern Europe

 

899

?

899

 

4.7%

6.1%

6.1%

945

?

 

945

(27)

972

?

972

 

Middle East & Africa

 

768

?

768

 

23.0%

26.6%

26.6%

1,065

?

 

1,065

6

1,059

?

1,059

 

South & Southeast Asia

 

1,071

?

1,071

 

(0.6)%

(1.1)%

(1.1)%

1,523

?

 

1,523

(7)

1,530

?

1,530

 

East Asia & Australia

 

1,358

?

1,358

 

12.2%

12.7%

12.7%

456

?

 

456

20

436

?

436

 

Americas

 

400

?

400

 

14.0%

9.0%

9.0%

$ 8,122

$ ?

 

$ 8,122

$ 107

$ 8,015

$ 2

$ 8,013

 

Total PMI

 

$ 7,446

$ ?

$ 7,446

 

9.1%

7.6%

7.6%

2021

Nine Months Ended

September 30,

 

2020

 

% Change

$ 9,250

$ ?

 

$ 9,250

$ 651

$ 8,599

$ 2

$ 8,597

 

European Union

 

$ 7,960

$ ?

$ 7,960

 

16.2%

8.0%

8.0%

2,632

?

 

2,632

(74)

2,706

?

2,706

 

Eastern Europe

 

2,470

?

2,470

 

6.6%

9.6%

9.6%

2,306

(246)

(1)

2,552

(66)

2,618

?

2,618

 

Middle East & Africa

 

2,348

?

2,348

 

8.7%

11.5%

11.5%

3,284

?

 

3,284

102

3,182

?

3,182

 

South & Southeast Asia

 

3,211

?

3,211

 

2.3%

(0.9)%

(0.9)%

4,509

?

 

4,509

101

4,408

?

4,408

 

East Asia & Australia

 

4,045

?

4,045

 

11.5%

9.0%

9.0%

1,320

?

 

1,320

38

1,282

?

1,282

 

Americas

 

1,216

?

1,216

 

8.6%

5.4%

5.4%

$ 23,301

$ (246)

 

$ 23,547

$ 752

$ 22,795

$ 2

$ 22,793

 

Total PMI

 

$ 21,250

$ ?

$ 21,250

 

10.8%

7.3%

7.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Represents the Saudi Arabia customs assessments

     

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 6

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Adjustments of Operating Income for the Impact of Currency and Acquisitions

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating
Income

Currency

Operating
Income
excluding
Currency

Acquisitions

Operating
Income
excluding
Currency &
Acquisitions

 

 

 

Operating
Income

 

Total

Excluding
Currency

Excluding
Currency &
Acquisitions

2021

 

Quarters Ended

September 30,

 

2020

 

% Change

$ 1,680

(1)

$ 79

$ 1,601

$ ?

$ 1,601

 

European Union

 

$ 1,588

 

 

5.8%

0.8%

0.8%

338

(1)

30

308

?

308

 

Eastern Europe

 

245

 

 

38.0%

25.7%

25.7%

388

(1)

(29)

417

?

417

 

Middle East & Africa

 

261

 

 

48.7%

59.8%

59.8%

348

(1)

4

344

?

344

 

South & Southeast Asia

 

402

 

 

(13.4)%

(14.4)%

(14.4)%

631

(1)

(23)

654

?

654

 

East Asia & Australia

 

637

 

 

(0.9)%

2.7%

2.7%

121

(1)

4

117

?

117

 

Americas

 

110

 

 

10.0%

6.4%

6.4%

(51)

(2)

?

(51)

?

(51)

 

Other

 

?

 

 

?%

?%

?%

$ 3,455

 

$ 65

$ 3,390

$ ?

$ 3,390

 

Total PMI

 

$ 3,243

 

 

6.5%

4.5%

4.5%

2021

 

Nine Months Ended

September 30,

 

2020

 

% Change

$ 4,811

(3)

$ 413

$ 4,398

$ ?

$ 4,398

 

European Union

 

$ 3,924

(5)

 

22.6%

12.1%

12.1%

913

(3)

(2)

915

?

915

 

Eastern Europe

 

610

(5)

 

49.7%

50.0%

50.0%

739

(4)

(74)

813

?

813

 

Middle East & Africa

 

819

(5)

 

(9.8)%

(0.7)%

(0.7)%

1,208

(3)

36

1,172

?

1,172

 

South & Southeast Asia

 

1,290

(5)

 

(6.4)%

(9.1)%

(9.1)%

2,041

(3)

(6)

2,047

?

2,047

 

East Asia & Australia

 

1,792

(5)

 

13.9%

14.2%

14.2%

367

(3)

12

355

?

355

 

Americas

 

328

(5)

 

11.9%

8.2%

8.2%

(51)

(2)

?

(51)

?

(51)

 

Other

 

?

 

 

?%

?%

?%

$ 10,028

 

$ 379

$ 9,649

$ ?

$ 9,649

 

Total PMI

 

$ 8,763

 

 

14.4%

10.1%

10.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes asset impairment and exit costs: EU ($12 million), EE ($2 million), ME&A ($3 million), S&SA ($4 million), EA&A ($21 million) and AMCS ($1 million)

(2) Includes asset acquisition cost ($51 million) related to OtiTopic Inc. in August 2021

(3) Includes asset impairment and exit costs: EU ($56 million), EE ($11 million), S&SA ($17 million), EA&A ($67 million) and AMCS ($6 million)

(4) Includes the Saudi Arabia customs assessments ($246 million) and asset impairment and exit costs ($13 million)

(5) Includes asset impairment and exit costs: EU ($27 million), EE ($7 million), ME&A ($9 million), S&SA ($11 million), EA&A ($13 million) and AMCS ($4 million)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 7

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Reconciliation of Operating Income to Adjusted Operating Income, excluding Currency and Acquisitions

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating
Income

Asset
Impairment
& Exit Costs
and Others

Adjusted
Operating
Income

Currency

Adjusted
Operating
Income
excluding
Currency

Acqui-
sitions

Adjusted
Operating
Income
excluding
Currency
& Acqui-
sitions

 

 

 

Operating
Income

Asset
Impairment
& Exit Costs

Adjusted
Operating
Income

 

Total

Excluding
Currency

Excluding
Currency
& Acqui-
sitions

2021

 

Quarters Ended

September 30,

 

2020

 

% Change

$ 1,680

$ (12)

(1)

$ 1,692

$ 79

$ 1,613

$ ?

$ 1,613

 

European Union

 

$ 1,588

$ ?

 

$ 1,588

 

6.5%

1.6%

1.6%

338

(2)

(1)

340

30

310

?

310

 

Eastern Europe

 

245

?

 

245

 

38.8%

26.5%

26.5%

388

(3)

(1)

391

(29)

420

?

420

 

Middle East & Africa

 

261

?

 

261

 

49.8%

60.9%

60.9%

348

(4)

(1)

352

4

348

?

348

 

South & Southeast Asia

 

402

?

 

402

 

(12.4)%

(13.4)%

(13.4)%

631

(21)

(1)

652

(23)

675

?

675

 

East Asia & Australia

 

637

?

 

637

 

2.4%

6.0%

6.0%

121

(1)

(1)

122

4

118

?

118

 

Americas

 

110

?

 

110

 

10.9%

7.3%

7.3%

(51)

(51)

(2)

?

?

?

?

?

 

Other

 

?

?

 

?

 

?%

?%

?%

$ 3,455

$ (94)

 

$ 3,549

$ 65

$ 3,484

$ ?

$ 3,484

 

Total PMI

 

$ 3,243

$ ?

 

$ 3,243

 

9.4%

7.4%

7.4%

2021

Nine Months Ended

September 30,

 

2020

 

% Change

$ 4,811

$ (56)

(1)

$ 4,867

$ 413

$ 4,454

$ ?

$ 4,454

 

European Union

 

$ 3,924

$ (27)

(1)

$ 3,951

 

23.2%

12.7%

12.7%

913

(11)

(1)

924

(2)

926

?

926

 

Eastern Europe

 

610

(7)

(1)

617

 

49.8%

50.1%

50.1%

739

(259)

(3)

998

(74)

1,072

?

1,072

 

Middle East & Africa

 

819

(9)

(1)

828

 

20.5%

29.5%

29.5%

1,208

(17)

(1)

1,225

36

1,189

?

1,189

 

South & Southeast Asia

 

1,290

(11)

(1)

1,301

 

(5.8)%

(8.6)%

(8.6)%

2,041

(67)

(1)

2,108

(6)

2,114

?

2,114

 

East Asia & Australia

 

1,792

(13)

(1)

1,805

 

16.8%

17.1%

17.1%

367

(6)

(1)

373

12

361

?

361

 

Americas

 

328

(4)

(1)

332

 

12.3%

8.7%

8.7%

(51)

(51)

(2)

?

?

?

?

?

 

Other

 

?

?

 

?

 

?%

?%

?%

$ 10,028

$ (467)

 

$ 10,495

$ 379

$ 10,116

$ ?

$ 10,116

 

Total PMI

 

$ 8,763

$ (71)

 

$ 8,834

 

18.8%

14.5%

14.5%

 

   

(1) Represents asset impairment and exit costs

(2) Represents asset acquisition cost related to OtiTopic Inc. in August 2021

(3) Includes the Saudi Arabia customs assessments ($246 million) and asset impairment and exit costs ($13 million)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 8

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Reconciliation of Adjusted Operating Income Margin, excluding Currency and Acquisitions

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted
Operating
Income
(1)

Adjusted
Net
Revenues
(2)

Adjusted
Operating
Income
Margin

 

Adjusted
Operating
Income
excluding
Currency
(1)

Adjusted
Net
Revenues
excluding
Currency
(2)

Adjusted
Operating
Income
Margin
excluding
Currency

 

Adjusted
Operating
Income
excluding
Currency
& Acqui-
sitions (1)

Adjusted
Net
Revenues
excluding
Currency
& Acqui-
sitions (2)

Adjusted
Operating
Income
Margin
excluding
Currency
& Acqui-
sitions

 

 

 

Adjusted
Operating
Income
(1)

Adjusted
Net
Revenues
(2)

Adjusted
Operating
Income
Margin

 

Adjusted
Operating
Income
Margin

Adjusted
Operating
Income
Margin
excluding
Currency

Adjusted
Operating
Income
Margin
excluding
Currency
& Acqui-
sitions

2021

 

Quarters Ended

September 30,

 

2020

 

% Points Change

$ 1,692

$ 3,192

53.0

%

 

$ 1,613

$ 3,064

52.6

%

 

$ 1,613

$ 3,062

52.7

%

 

European Union

 

$ 1,588

$ 2,950

53.8

%

 

(0.8)

 

(1.2)

 

(1.1)

 

340

941

36.1

%

 

310

954

32.5

%

 

310

954

32.5

%

 

Eastern Europe

 

245

899

27.3

%

 

8.8

 

5.2

 

5.2

 

391

945

41.4

%

 

420

972

43.2

%

 

420

972

43.2

%

 

Middle East & Africa

 

261

768

34.0

%

 

7.4

 

9.2

 

9.2

 

352

1,065

33.1

%

 

348

1,059

32.9

%

 

348

1,059

32.9

%

 

South & Southeast Asia

 

402

1,071

37.5

%

 

(4.4)

 

(4.6)

 

(4.6)

 

652

1,523

42.8

%

 

675

1,530

44.1

%

 

675

1,530

44.1

%

 

East Asia & Australia

 

637

1,358

46.9

%

 

(4.1)

 

(2.8)

 

(2.8)

 

122

456

26.8

%

 

118

436

27.1

%

 

118

436

27.1

%

 

Americas

 

110

400

27.5

%

 

(0.7)

 

(0.4)

 

(0.4)

 

$ 3,549

$ 8,122

43.7

%

 

$ 3,484

$ 8,015

43.5

%

 

$ 3,484

$ 8,013

43.5

%

 

Total PMI

 

$ 3,243

$ 7,446

43.6

%

 

0.1

 

(0.1)

 

(0.1)

 

2021

Nine Months Ended

September 30,

 

2020

 

% Points Change

$ 4,867

$ 9,250

52.6

%

 

$ 4,454

$ 8,599

51.8

%

 

$ 4,454

$ 8,597

51.8

%

 

European Union

 

$ 3,951

$ 7,960

49.6

%

 

3.0

 

2.2

 

2.2

 

924

2,632

35.1

%

 

926

2,706

34.2

%

 

926

2,706

34.2

%

 

Eastern Europe

 

617

2,470

25.0

%

 

10.1

 

9.2

 

9.2

 

998

2,552

39.1

%

 

1,072

2,618

40.9

%

 

1,072

2,618

40.9

%

 

Middle East & Africa

 

828

2,348

35.3

%

 

3.8

 

5.6

 

5.6

 

1,225

3,284

37.3

%

 

1,189

3,182

37.4

%

 

1,189

3,182

37.4

%

 

South & Southeast Asia

 

1,301

3,211

40.5

%

 

(3.2)

 

(3.1)

 

(3.1)

 

2,108

4,509

46.8

%

 

2,114

4,408

48.0

%

 

2,114

4,408

48.0

%

 

East Asia & Australia

 

1,805

4,045

44.6

%

 

2.2

 

3.4

 

3.4

 

373

1,320

28.3

%

 

361

1,282

28.2

%

 

361

1,282

28.2

%

 

Americas

 

332

1,216

27.3

%

 

1.0

 

0.9

 

0.9

 

$ 10,495

$ 23,547

44.6

%

 

$ 10,116

$ 22,795

44.4

%

 

$ 10,116

$ 22,793

44.4

%

 

Total PMI

 

$ 8,834

$ 21,250

41.6

%

 

3.0

 

2.8

 

2.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) For the calculation of Adjusted Operating Income and Adjusted Operating Income excluding currency and acquisitions refer to Schedule 7

(2) For the calculation of Adjusted Net Revenues excluding currency and acquisitions refer to Schedule 5

 

 

 

 

 

 

 

 

Schedule 9

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Condensed Statements of Earnings

($ in millions, except per share data) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarters Ended September 30,

 

 

 

Nine Months Ended September 30,

2021

 

 

2020

 

 

Change

Fav./(Unfav.)

 

 

 

2021

 

 

2020

 

 

Change

Fav./(Unfav.)

$ 21,617

 

 

$ 20,444

 

 

5.7

%

 

Revenues including Excise Taxes (1)

 

$ 61,393

 

 

$ 56,516

 

8.6

%

13,495

 

 

12,998

 

 

(3.8

)%

 

Excise Taxes on products

 

38,092

 

 

35,266

 

 

(8.0

)%

8,122

 

 

7,446

 

 

9.1

%

 

Net Revenues (1)

 

23,301

 

 

21,250

 

 

9.7

%

2,596

 

 

2,416

 

 

(7.5

)%

 

Cost of sales

 

7,223

 

 

6,997

 

 

(3.2

)%

5,526

 

 

5,030

 

 

9.9

%

 

Gross profit

 

16,078

 

 

14,253

 

 

12.8

%

2,053

 

 

1,769

 

 

(16.1

)%

 

Marketing, administration and research costs (2)

 

5,995

 

 

5,435

 

 

(10.3

)%

18

 

 

18

 

 

 

 

Amortization of intangibles

 

55

 

 

55

 

 

 

3,455

 

 

3,243

 

 

6.5

%

 

Operating Income

 

10,028

 

 

8,763

 

 

14.4

%

154

 

 

163

 

 

5.5

%

 

Interest expense, net

 

482

 

 

454

 

 

(6.2

)%

27

 

 

23

 

 

(17.4

)%

 

Pension and other employee benefit costs

 

82

 

 

68

 

 

(20.6

)%

3,274

 

 

3,057

 

 

7.1

%

 

Earnings before income taxes

 

9,464

 

 

8,241

 

 

14.8

%

735

 

 

640

 

 

(14.8

)%

 

Provision for income taxes

 

2,078

 

 

1,764

 

 

(17.8

)%

(49

)

 

(20

)

 

 

 

Equity investments and securities (income)/loss, net

 

(95

)

 

4

 

 

 

2,588

 

 

2,437

 

 

6.2

%

 

Net Earnings

 

7,481

 

 

6,473

 

 

15.6

%

162

 

 

130

 

 

 

 

Net Earnings attributable to noncontrolling interests

 

465

 

 

393

 

 

 

$ 2,426

 

 

$ 2,307

 

 

5.2

%

 

Net Earnings attributable to PMI

 

$ 7,016

 

 

$ 6,080

 

 

15.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per share data (3):

 

 

 

 

 

 

$ 1.55

 

 

$ 1.48

 

 

4.7

%

 

Basic Earnings Per Share

 

$ 4.49

 

 

$ 3.90

 

 

15.1

%

$ 1.55

 

 

$ 1.48

 

 

4.7

%

 

Diluted Earnings Per Share

 

$ 4.48

 

 

$ 3.90

 

 

14.9

%

(1) Nine months ended September 30, 2021 includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments

(2) Quarter ended September 30, 2021 includes asset acquisition cost ($51 million) related to OtiTopic Inc. in August 2021 and asset impairment and exit costs ($43 million). Nine months ended September 30, 2021 includes asset acquisition cost ($51 million) and asset impairment and exit costs ($170 million). Nine months ended September 30, 2020 includes asset impairment and exit costs ($71 million)

(3) Net Earnings and weighted-average shares used in the basic and diluted Earnings Per Share computations for the quarters and for the nine months ended September 30, 2021 and 2020 are shown on Schedule 1, Footnote 1

 

 

 

 

 

Schedule 10

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Condensed Balance Sheets

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

September 30,

 

December 31,

 

 

2021

 

2020

Assets

 

 

 

 

 

 

Cash and cash equivalents

 

 

$

4,491

 

 

 

$

7,280

 

All other current assets

 

 

13,355

 

 

 

14,212

 

Property, plant and equipment, net

 

 

6,061

 

 

 

6,365

 

Goodwill

 

 

6,814

 

 

 

5,964

 

Other intangible assets, net

 

 

2,893

 

 

 

2,019

 

Equity investments

 

 

4,624

 

 

 

4,798

 

Other assets

 

 

3,351

 

 

 

4,177

 

Total assets

 

 

$

41,589

 

 

 

$

44,815

 

 

 

 

 

 

 

 

Liabilities and Stockholders' (Deficit) Equity

 

 

 

 

 

 

Short-term borrowings

 

 

$

223

 

 

 

$

244

 

Current portion of long-term debt

 

 

3,114

 

 

 

3,124

 

All other current liabilities

 

 

14,540

 

 

 

16,247

 

Long-term debt

 

 

25,768

 

 

 

28,168

 

Deferred income taxes

 

 

720

 

 

 

684

 

Other long-term liabilities

 

 

5,856

 

 

 

6,979

 

Total liabilities

 

 

50,221

 

 

 

55,446

 

 

 

 

 

 

 

 

Total PMI stockholders' deficit

 

 

(10,551

)

 

 

(12,567

)

Noncontrolling interests

 

 

1,919

 

 

 

1,936

 

Total stockholders' (deficit) equity

 

 

(8,632

)

 

 

(10,631

)

Total liabilities and stockholders' (deficit) equity

 

 

$

41,589

 

 

 

$

44,815

 

 

 

 

 

 

 

 

 

 

 

Schedule 11

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Calculation of Total Debt to Adjusted EBITDA and Net Debt to Adjusted EBITDA Ratios

($ in millions, except ratios) / (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended September 30, 2021

 

Year Ended
December 31,
2020

 

October ~
December

 

January ~
September

 

12 months

 

 

2020

 

2021

 

rolling

 

Net Earnings

 

$

2,119

 

 

 

$

7,481

 

 

 

$

9,600

 

 

 

$

8,592

 

Equity investments and securities (income)/loss, net

 

(20

)

 

 

(95

)

 

 

(115

)

 

 

(16

)

Provision for income taxes

 

613

 

 

 

2,078

 

 

 

2,691

 

 

 

2,377

 

Interest expense, net

 

164

 

 

 

482

 

 

 

646

 

 

 

618

 

Depreciation and amortization

 

272

 

 

 

719

 

 

 

991

 

 

 

981

 

Asset impairment and exit costs and Others (1)

 

(41

)

 

 

467

 

 

 

426

 

 

 

30

 

Adjusted EBITDA

 

$

3,107

 

 

 

$

11,132

 

 

 

$

14,239

 

 

 

$

12,582

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30,

 

December 31,

 

 

 

 

 

 

 

2021

 

2020

Short-term borrowings

 

 

 

 

 

 

 

$

223

 

 

 

$

244

 

Current portion of long-term debt

 

 

 

 

 

 

 

3,114

 

 

 

3,124

 

Long-term debt

 

 

 

 

 

 

 

25,768

 

 

 

28,168

 

Total Debt

 

 

 

 

 

 

 

$

29,105

 

 

 

$

31,536

 

Cash and cash equivalents

 

 

 

 

 

 

 

4,491

 

 

 

7,280

 

Net Debt

 

 

 

 

 

 

 

$

24,614

 

 

 

$

24,256

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratios:

 

 

 

 

 

 

 

 

 

 

 

Total Debt to Adjusted EBITDA

 

 

 

 

 

 

 

2.04

 

 

 

2.51

 

Net Debt to Adjusted EBITDA

 

 

 

 

 

 

 

1.73

 

 

 

1.93

 

(1) For the period January 2021 to September 2021 "Others" includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments that was recorded in the second quarter of 2021 and asset acquisition cost of $51 million related to OtiTopic Inc. in August 2021. For the period October 2020 to December 2020 and for the year ended December 31, 2020, "Others" include the Brazil indirect tax credit $119 million that was recorded in the fourth quarter of 2020.

 

 

 

 

 

 

 

Schedule 12

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries

Reconciliation of Non-GAAP Measures

Reconciliation of Operating Cash Flow to Operating Cash Flow, excluding Currency

($ in millions) / (Unaudited)

 

 

 

 

 

 

 

 

 

Quarters Ended September 30,

 

 

 

Nine Months Ended September 30,

2021

2020

% Change

 

 

 

2021

2020

% Change

$ 3,870

$ 3,614

7.1%

 

Net cash provided by operating activities (1)

 

$ 7,935

$ 6,650

19.3%

140

 

 

 

Less: Currency

 

759

 

 

$ 3,730

$ 3,614

3.2%

 

Net cash provided by operating activities,

excluding currency

 

$ 7,176

$ 6,650

7.9%

 

 

 

 

 

 

 

 

 

(1) Operating cash flow

 


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: